Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2311
https://www.valueinhealthjournal.com/article/S1098-3015(14)04241-7/fulltext
Title :
Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04241-7&doi=10.1016/j.jval.2014.08.2311
First page :
A641
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1767